Figure 4. Meta-analysis results for invasive breast cancer.

Figure 4Meta-analysis results for invasive breast cancer

* per 1.000 women-years

# Veronesi, 2007 and Barrett-Connor, 2006 reported mean or median duration of the actual treatment period.

& The analysis included data from both MORE and CORE. Participants from MORE had 4-year treatment and those who continued in CORE had 4 additional years of treatment The total follow-up time is averaged over both MORE and CORE for 7705 participants.

From: Results

Cover of Comparative Effectiveness of Medications To Reduce Risk of Primary Breast Cancer in Women
Comparative Effectiveness of Medications To Reduce Risk of Primary Breast Cancer in Women [Internet].
AHRQ Comparative Effectiveness Reviews, No. 17.
Nelson HD, Fu R, Humphrey L, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.